| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $343M | $315M | — | 8.9% | — |
| Op. Income | $97M | $75M | — | 30.6% | — |
| Gross Margin | 36.3% | 50.2% | — | -13.9pp | — |
| Net Margin | 22.7% | 18.6% | — | 4.1pp | — |
| EPS (Diluted) | $0.77 | $0.58 | — | 32.8% | — |
| Free Cash Flow | $79M | $133M | — | -40.7% | — |
| Item | Amount |
|---|---|
| REVENUE | $343M |
| Cost of Revenue | $219M |
| GROSS PROFIT | $124M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $27M |
| Other Expenses | $0 |
| Operating Expenses | $27M |
| Cost & Expenses | $246M |
| OPERATING INCOME | $97M |
| Interest Income | $4M |
| Interest Expense | $24M |
| Other Income/Expenses | -$19M |
| INCOME BEFORE TAX | $79M |
| Income Tax Expense | $1M |
| Net Income from Continuing Ops | $78M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $78M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $78M |
| D&A | $53M |
| EBIT | $103M |
| EBITDA | $156M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $343M |
| Cost of Revenue | $219M |
| GROSS PROFIT | $124M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $27M |
| Other Expenses | $0 |
| Operating Expenses | $27M |
| Cost & Expenses | $246M |
| OPERATING INCOME | $97M |
| Interest Income | $4M |
| Interest Expense | $24M |
| Other Income/Expenses | -$19M |
| INCOME BEFORE TAX | $79M |
| Income Tax Expense | $1M |
| Net Income from Continuing Ops | $78M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $78M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $78M |
| D&A | $53M |
| EBIT | $103M |
| EBITDA | $156M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $78M |
| Depreciation & Amortization | $53M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $10M |
| Change in Working Capital | -$27M |
| OPERATING CASH FLOW | $114M |
| Capital Expenditure | -$35M |
| Acquisitions (Net) | $31M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$5M |
| Net Debt Issuance | -$230M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$37M |
| Other Financing Activities | $128.6K |
| NET CASH FROM FINANCING | -$267M |
| FREE CASH FLOW | $79M |
| Net Change in Cash | -$151M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $219M |
| Short-Term Investments | $0 |
| Net Receivables | $208M |
| Inventory | $65M |
| Other Current Assets | $12M |
| TOTAL CURRENT ASSETS | $516M |
| PP&E (Net) | $2.7B |
| Goodwill | $2M |
| Intangible Assets | $2M |
| Long-Term Investments | $5M |
| Tax Assets | $298.8K |
| Other Non-Current Assets | $0 |
| TOTAL NON-CURRENT ASSETS | $2.7B |
| TOTAL ASSETS | $3.2B |
| Account Payables | $36M |
| Short-Term Debt | $121M |
| Deferred Revenue | $2M |
| Other Current Liabilities | $57M |
| TOTAL CURRENT LIABILITIES | $218M |
| Long-Term Debt | $764M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $199.2K |
| Other Non-Current Liabilities | $48M |
| TOTAL NON-CURRENT LIABILITIES | $823M |
| TOTAL LIABILITIES | $1.0B |
| Common Stock | $996.1K |
| Additional Paid-In Capital | $91M |
| Retained Earnings | $1.7B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $366M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $2.1B |
| Minority Interest | $0 |
| TOTAL EQUITY | $2.1B |
| TOTAL LIABILITIES & EQUITY | $3.2B |
| Total Debt | $896M |
| Net Debt | $677M |
